Pharmaceutical firms and the construction of drug markets: From branding to scientific marketing

History and Technology

Volumn 29, Issue 2, 2013, Pages 105-115

  Gaudillière, Jean Paul ^a   Thoms, Ulrike ^b  

^a ÉCOLE DES HAUTES ÉTUDES EN SCIENCES SOCIALES   (France)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887985062     PISSN: 07341512     EISSN: 14772620     Source Type: Journal    
DOI: 10.1080/07341512.2013.828867     Document Type: Editorial

References (67)

1. Abraham, John. 1995. Science, Politics and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation. London: Routledge.
2. Ammann, Klaus, and Christian Engler. Husten, Schmerz und Kommunismus: Das Basler Pharma-Unternehmen F. Hoffmann-La Roche in Osteuropa 1896-1957. Zurich: Chronos Verlag, 2007.
3. Bächi, Beat. 2009. Vitamin C für Alle! Pharmazeutische Produktion, Vermarktung und Gesundheitspolitik (1933-1953). Zurich: Chronos Verlag.
4. Bartmann, Wilhelm. 2003. Zwischen Tradition und Fortschritt: Aus der Geschichte der Pharmabereiche von Bayer, Hoechst und Schering von 1935-1975. Stuttgart: Franz Steiner Verlag.
5. Bäumler, Ernst. 1989. Farben, Formeln, Forscher: Hoechst und die Geschichte der industriellen Chemie in Deutschland. Munich: Piper.
6. Berghoff, Hartmut, ed. Marketinggeschichte: Die Genese einer modernen Sozialtechnik. Frankfurt am Main: Campus Verlag GmbH, 2007.
7. Berghoff, Hartmut, Philip Scranton, and Uwe Spiekermann, eds. The Rise of Marketing and Market Research. Basingstoke: Palgrave Macmillan, 2012.
8. Bud, Robert. 2007. Penicillin: Triumph and Tragedy. Oxford: Oxford University Press.
9. Bürgi, Michael. 2011. Pharmaforschung im 20. Jahrhundert: Arbeit an der Grenze zwischen Hochschule und Industrie. Zurich: Chronos.
10. Carpenter, Daniel. 2010. Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. Princeton: Princeton University Press.
11. Carpenter, Daniel. 2013. "Corrosive Capture? The Dueling Forces of Autonomy and Industry Influence in FDA Pharmaceutical Regulation." In Preventing Regulatory Capture: Special Interest Influence and How to Limit It, edited by D. Carpenter and D. A. Moss, 152-172. Cambridge: Cambridge University Press.
12. Cassier, Maurice. 2008. "Patents and Public Health in France. Pharmaceutical Patent Law in-the-Making at the Patent Office between the Two World Wars." History and Technology 24: 135-151.
13. Chatriot, Alain, Marie-Emmanuelle Chessel, and Matthew Hilton, eds. The Expert Consumer: Associations and Professionals in Consumer Society. Aldershot: Ashgate, 2006.
14. Chauveau, Sophie. L'invention pharmaceutique. La pharmacie française entre l'État et la société au XXe siècle. Paris: Institut d'édition Sanofi-Synthélabo, 1999.
15. Church, Roy. 2005. "The British Market for Medicine in the late Nineteenth Century: The Innovative Impact of S M Burroughs & Co." Medical History 49(3): 281-298.
16. Cohen, Lizabeth. A Consumers' Republic. The Politics of Mass Consumption in Postwar America. New York: Alfred A. Knopf, 2003.
17. Cramer, Tobias. 2010. Die Rückkehr ins Pharmageschäft. Marktstrategien der Farbenfabriken vorm. Friedr. Bayer & Co in Lateinamerika nach dem Ersten Weltkrieg. Berlin: Wissenschaftlicher Verlag.
18. Dixon, Donald F. 'Consumer Sovereignty, Democracy, and the Marketing Concept: A Macromarketing Perspective'. In History of Marketing Thought, edited by M. Tadajewski, Vol. III, 330-345. Los Angeles: Sage Publications, 2008.
19. Gasteiger, Nepomuk. Der Konsument. Verbraucherbilder in Werbung, Konsumkritik und Verbraucherschutz 1945-1989. Frankfurt am Main: Campus Verlag, 2010.
20. Gaudillière, Jean-Paul. 2008. "How Pharmaceuticals Became Patentable: The Production and Appropriation of Drugs in the Twentieth Century." History and Technology 24: 99-106.
21. Gaudillière, Jean-Paul. 2005. "Introduction: Drug Trajectories." Studies in History and Philosophy of Biological and Biomedical Sciences 36(4): 603-611.
22. Gaudillière, Jean-Paul, and Volker Hess. 2012. Ways of Regulating Drugs in the 19th and 20th Centuries. Basingstoke: Palgrave Macmillan.
23. Gaudillière, Jean-Paul, and Ilana Löwy. 1998. The Invisible Industrialist: Manufactures and the Production of Scientific Knowledge. Basingstoke: Palgrave Macmillan.
24. Goodman, Jordan, and Vivien Walsh. 2001. The Story of Taxol: Nature and Politics in the Pursuit of an Anti-Cancer Drug. Cambridge: Cambridge University Press.
25. Grazia, Victoria de. Irresistible Empire: America's Advance through Twentieth-Century Europe. Cambridge, MA: Harvard University Press, 2005.
26. Greene, Jeremy A. 2007. Prescribing by Numbers: Drugs and the Definition of Disease. Baltimore, MD: Johns Hopkins University Press.
27. Greene, Jeremy, and Elizabeth Siegel Watkins, eds. Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America. Baltimore: The Johns Hopkins University Press, 2012.
28. Haller, Lea. 2012. Cortison: Geschichte eines Hormons, 1900-1955. Zürich: Chronos Verlag.
29. Haupt, Heinz-Gerhard, and Claudius Torp. 2009. Die Konsumgesellschaft in Deutschland 1890-1990: Ein Handbuch. Frankfurt am Main: Campus Verlag.
30. Healy, David. 2004. Let Them Eat Prozac: The Unhealthy Relationship between the Pharmaceutical Industry and Depression. New York, NY: New York University Press.
31. Herzberg, David. 2009. Happy Pills in America: From Miltown to Prozac. Baltimore, MD: The John Hopkins University Press.
32. IGAS (Inspection Générale des Affaires Sociales). Enquête sur le Médiator - Rapport Définitif, RM-2011-001P, 2011. http://www.ladocumentationfrancaise.fr/rapports-publics/114000028-enquete-sur-le-mediator-R (accessed 8 July 2013).
33. IGAS. Rapport sur la pharmacovigilance et gouvernance de la chaîne du médicament, RM-2011-103P. http://www.ladocumentationfrancaise.fr/rapports-publics/114000331/index.shtml (accessed 8 July 2013).
34. Keating, Peter, and Alberto Cambrosio. 2012. Cancer on Trial: Oncology as a New Style of Practice. London: The University of Chicago Press.
35. Kleinschmidt, Christian L. 2006. "Konsumgesellschaft, Verbraucherschutz und Soziale Marktwirtschaft. Verbraucherpolitische Aspekte des "Modell Deutschland" (1947-1975)." Jahrbuch für Wirtschaftsgeschichte 1: 13-28.
36. Kobrak, Christopher. 2002. National Cultures and International Competition: The Experience of Schering AG 1851-1950. Cambridge: Cambridge University Press.
37. Leach, William R. 1993. Land of Desire: Merchants, Power, and the Rise of a New American Culture. New York, NY: Pantheon Books.
38. Lesch, John E., ed. The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine. Oxford: Oxford University Press, 2007.
39. Liebenau, Jonathan. 1984. "Industrial R&D in Pharmaceutical Firms in the Early Twentieth Century." Business History Review 26(3): 329-346.
40. Liebenau, Jonathan. 1985. "Scientific Ambitions: The Pharmaceutical Industry 1900-1920." Pharmacy in History 27: 3-11.
41. Löwy, Ilana. 1996. Between Bench and Bedside: Science, Healing and Interleukin-2 in a Cancer Ward. Cambridge, MA: Harvard University Press.
42. Marks, Harry. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990. Cambridge, UK: Cambridge University Press, 1990.
43. Moffitt, Susan L. 2010. "Promoting Agency Reputation through Public Advice: Advisory Committee Use in the FDA." The Journal of Politics 72(3): 880-893.
44. Peyer, Hans Conrad. Roche - Geschichte eines Unternehmens 1896-1996. Basel: Editions Roche, 1996.
45. Quirke, Viviane. 2007. Collaboration in the Pharmaceutical Drug Industry: Changing Relationships in Britain and France 1933-1965. New York, NY: Routledge.
46. Quirke, Viviane. 2005. "Making British Cortisone: Glaxo and the Development of Corticosteroids in the 1950s-1960s." Studies in History and Philosophy of Biological and Biomedical Sciences 36(4): 645-674.
47. Quirke, Viviane, and Judy Slinn, eds. Perspectives on Twentieth-Century Pharmaceuticals. Bern: Peter Lang AG, 2009.
48. Rasmussen, Nicolas. 2004. "The Moral Economy of the Drug Company-Medical Scientist Collaboration in Interwar America." Social Studies of Science 34(2): 161-185.
49. Rasmussen, Nicolas. 2008. On Speed: The Many Lives of Amphetamine. New York, NY: New York University Press.
50. Ratmoko, Christina. Damit die Chemie stimmt. Die Anfänge der industriellen Herstellung von weiblichen und männlichen Sexualhormonen 1914-1938. Zürich: Chronos Verlag, 2010.
51. Schwarzkopf, Stefan. 2011. "The Consumer as "Voter", "Judge", and "Jury": Historical Origins and Political Consequences of a Marketing Myth." Journal of Macromarketing 31(1): 8-18.
52. Watkins, Siegel. 2001. Elizabeth. On the Pill. A Social History of Oral Contraceptives. Baltimore: Johns Hopkins University Press.
53. Silies, Eva-Maria. Liebe, Lust und Last: Die Pille als weibliche Generationenerfahrung in der Bundesrepublik 1960-1980. Göttingen: Wallstein, 2010.
54. Stearns, Peter N. 2001. Consumerism in World History: The Global Transformation of Desire. New York, NY: Routledge.
55. Straumann, Lukas, and Daniel Wildmann. 2001. Schweizer Chemieunternehmen im 'Dritten Reich'. Zurich: Chronos Verlag.
56. Swann, John P. 1988. Academic Scientists and the Pharmaceutical Industry: Cooperative Research in Twentieth Century America. Baltimore, MD: Johns Hopkins University Press.
57. Tadajewski, Mark, ed. The History of Marketing Thought, Vols. I-III. Los Angeles, CA: Sage Publications, 2008.
58. Tedlow, Richard S. 1990. New and Improved: The Story of Mass Marketing in America. New York, NY: Basic Books.
59. Tedlow, Richard S., and Geoffrey Jones, eds. The Rise and Fall of Mass Marketing. New York: Routledge, 1993.
60. Thoms, Ulrike. 'The Contraceptive Pill, the Pharmaceutical Industry and Changes in the Patient-Doctor Relationship in Germany'. In Gendered Drug Standards from Historical and Socio-Anthropological Perspectives, edited by T. Ortiz Gómez, M. J. Santesmases, A. Ignaciuk and N. F. Tschudy. London: Ashgate (Forthcoming).
61. Tobbell, Dominique. 2012. Pills, Power, and Policy: The Struggle for Drug Reform in Cold War America and its Consequences. Berkeley: University of California Press.
62. Tomes, Nancy. 2001. "Merchants of Health: Medicine and Consumer Culture in the United States, 1900-1940." Journal of American History 88(2): 519-547.
63. Tone, Andrea. 2009. The Age of Anxiety: A History of America's Turbulent Affair with Tranquilizers. New York: Basic Books.
64. Tone, Andrea, and Elizabeth Siegel Watkins, eds. Medicating Modern America: Prescription Drugs in History. New York: New York University Press, 2007.
65. Travis, Anthony S., Harm G. Schröter, Ernst Homburg, and Peter T. Morris. Determinants in the Evolution of the European Chemical Industry, 1900-1939: New Technologies, Political Frameworks, Markets, and Companies. Dordrecht: Kluwer Academic, 1998.
66. Trentmann, Frank, ed. The Making of the Consumer: Knowledge. Power and Identity in the Modern World. Oxford: Berg, 2006.
67. Wimmer, Wolfgang. 1994. Wir haben fast immer was Neues: Gesundheitswesen und Innovationen der Pharma-Industrie in Deutschland, 1880-1935. Berlin: Duncker & Humblot.